Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Bellile

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Nature Communications|March 20, 2026
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trialAlexander T Pearson, Jameel Muzaffar, Kedar Kirtane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.
Oral Oncology|June 30, 2024
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancerWilliam J Benjamin, Allen L Feng, Molly Heft Neal, et al.
The Laryngoscope|June 19, 2013
Biomarkers in advanced larynx cancerCarol R Bradford, Bhavna Kumar, Emily Bellile, et al.
Head & Neck|August 6, 2013
Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomaMatthew E Spector, K Kelly Gallagher, Emily Bellile, et al.
Plos One|January 30, 2013
Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsJustin A Colacino, Dana C Dolinoy, Sonia A Duffy, et al.
Microbiome|December 1, 2023
Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancerMarcell Costa de Medeiros, Stephanie The, Emily Bellile, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Head & Neck|January 29, 2020
Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatinPaul L Swiecicki, Pin Li, Emily Bellile, et al.
Head & Neck|December 17, 2025
Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the LarynxZachary Risch, Emily Bellile, Moneb S Bughrara, et al.
Nature Communications|March 20, 2026
MDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trialAlexander T Pearson, Jameel Muzaffar, Kedar Kirtane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Mitigating SOX2-potentiated Immune Escape of Head and Neck Squamous Cell Carcinoma with a STING-inducing Nanosatellite VaccineYee Sun Tan, Kanokwan Sansanaphongpricha, Yuying Xie, et al.
JAMA Otolaryngology-- Head & Neck Surgery|November 2, 2013
High-risk human papillomavirus detection in oropharyngeal, nasopharyngeal, and oral cavity cancers: comparison of multiple methodsHeather M Walline, Chris Komarck, Jonathan B McHugh, et al.
Oral Oncology|June 30, 2024
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancerWilliam J Benjamin, Allen L Feng, Molly Heft Neal, et al.
The Laryngoscope|June 19, 2013
Biomarkers in advanced larynx cancerCarol R Bradford, Bhavna Kumar, Emily Bellile, et al.
Head & Neck|August 6, 2013
Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomaMatthew E Spector, K Kelly Gallagher, Emily Bellile, et al.
Plos One|January 30, 2013
Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristicsJustin A Colacino, Dana C Dolinoy, Sonia A Duffy, et al.
Microbiome|December 1, 2023
Salivary microbiome changes distinguish response to chemoradiotherapy in patients with oral cancerMarcell Costa de Medeiros, Stephanie The, Emily Bellile, et al.
Pageof 8